Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. [electronic resource]
Producer: 20101228Description: 2009-17 p. digitalISSN:- 1474-547X
- Adolescent
- Antibiotics, Antineoplastic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Asparaginase -- administration & dosage
- Child
- Child, Preschool
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Humans
- Idarubicin -- therapeutic use
- Infant
- Kaplan-Meier Estimate
- Leukocyte Count
- Male
- Mercaptopurine -- administration & dosage
- Methotrexate -- administration & dosage
- Mitoxantrone -- therapeutic use
- Polyethylene Glycols -- administration & dosage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Recurrence
- Risk Assessment
- Treatment Outcome
- United Kingdom
- Vidarabine -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.